Literature DB >> 30363409

Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No.

Günter U Höglinger1,2.   

Abstract

http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2330-1619/homepage/mdc312582-sup-v001.htm.

Entities:  

Keywords:  4r‐tauopathies; corticobasal degeneration; progressive supranuclear palsy

Year:  2018        PMID: 30363409      PMCID: PMC6174469          DOI: 10.1002/mdc3.12582

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  26 in total

1.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

2.  Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.

Authors:  N Sergeant; A Wattez; A Delacourte
Journal:  J Neurochem       Date:  1999-03       Impact factor: 5.372

Review 3.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

Review 4.  The Differential Diagnosis and Treatment of Atypical Parkinsonism.

Authors:  Johannes Levin; Alexander Kurz; Thomas Arzberger; Armin Giese; Günter U Höglinger
Journal:  Dtsch Arztebl Int       Date:  2016-02-05       Impact factor: 5.594

5.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation.

Authors:  A Delacourte; N Sergeant; A Wattez; D Gauvreau; Y Robitaille
Journal:  Ann Neurol       Date:  1998-02       Impact factor: 10.422

6.  Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.

Authors:  T Komori; N Arai; M Oda; H Nakayama; H Mori; S Yagishita; T Takahashi; N Amano; S Murayama; S Murakami; N Shibata; M Kobayashi; S Sasaki; M Iwata
Journal:  Acta Neuropathol       Date:  1998-10       Impact factor: 17.088

7.  Corticodentatonigral degeneration with neuronal achromasia.

Authors:  J J Rebeiz; E H Kolodny; E P Richardson
Journal:  Arch Neurol       Date:  1968-01

8.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

View more
  8 in total

1.  Comment on "Is it Useful to Classify PSP and CBD as Different Disorders?"

Authors:  Anthony E Lang
Journal:  Mov Disord Clin Pract       Date:  2018-10-03

Review 2.  Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes.

Authors:  Ralph Buchert; Carsten Buhmann; Ivayla Apostolova; Philipp T Meyer; Jürgen Gallinat
Journal:  Dtsch Arztebl Int       Date:  2019-11-01       Impact factor: 5.594

3.  Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.

Authors:  Gesine Respondek; Max-Joseph Grimm; Ines Piot; Thomas Arzberger; Yaroslau Compta; Elisabet Englund; Leslie W Ferguson; Ellen Gelpi; Sigrun Roeber; Armin Giese; Murray Grossman; David J Irwin; Wassilios G Meissner; Christer Nilsson; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Günter U Höglinger
Journal:  Mov Disord       Date:  2019-09-30       Impact factor: 10.338

Review 4.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

5.  The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders.

Authors:  Daniel Alcolea; Jordi Clarimón; María Carmona-Iragui; Ignacio Illán-Gala; Estrella Morenas-Rodríguez; Isabel Barroeta; Roser Ribosa-Nogué; Isabel Sala; M Belén Sánchez-Saudinós; Laura Videla; Andrea Subirana; Bessy Benejam; Sílvia Valldeneu; Susana Fernández; Teresa Estellés; Miren Altuna; Miguel Santos-Santos; Lídia García-Losada; Alexandre Bejanin; Jordi Pegueroles; Víctor Montal; Eduard Vilaplana; Olivia Belbin; Oriol Dols-Icardo; Sònia Sirisi; Marta Querol-Vilaseca; Laura Cervera-Carles; Laia Muñoz; Raúl Núñez; Soraya Torres; M Valle Camacho; Ignasi Carrió; Sandra Giménez; Constance Delaby; Ricard Rojas-Garcia; Janina Turon-Sans; Javier Pagonabarraga; Amanda Jiménez; Rafael Blesa; Juan Fortea; Alberto Lleó
Journal:  Alzheimers Dement (N Y)       Date:  2019-10-14

Review 6.  Unravelling Genetic Factors Underlying Corticobasal Syndrome: A Systematic Review.

Authors:  Federica Arienti; Giulia Lazzeri; Maria Vizziello; Edoardo Monfrini; Nereo Bresolin; Maria Cristina Saetti; Marina Picillo; Giulia Franco; Alessio Di Fonzo
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

Review 7.  Four-Repeat Tauopathies: Current Management and Future Treatments.

Authors:  Lawren VandeVrede; Peter A Ljubenkov; Julio C Rojas; Ariane E Welch; Adam L Boxer
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

8.  Of Criteria and Men-Diagnosing Atypical Parkinsonism: Towards an Algorithmic Approach.

Authors:  Liviu Cozma; Mioara Avasilichioaei; Natalia Dima; Bogdan Ovidiu Popescu
Journal:  Brain Sci       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.